A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

In the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who ...

Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...

Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

With the active ingredient tirzepatide, studies indicate this drug is even more effective for weight loss than the semaglutide drugs. The two-pronged effect of Mounjaro involves both the GLP-1 ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped heavy drinkers cut alcohol consumption by nearly 70%.